Evidence map›Paper›PMID 35582320›Full record

ArticleThe mental health clinician2022

Best practice model for outpatient psychiatric pharmacy practice, part 1: Development of initial attribute statements.

Richard J Silvia, Kelly C Lee, Gregory H Payne, Jessica Ho, Carla Cobb, Elayne D Ansara, Clint A Ross

Abstract read
In one paragraph

Article in The mental health clinician, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Richard J SilviaProfessor of Clinical Pharmacy, University of California, San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, California.ORCID https://orcid.org/0000-0003-3089-4490
Kelly C LeeProfessor of Clinical Pharmacy, University of California, San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, California.ORCID https://orcid.org/0000-0002-1674-4210
Gregory H PayneDirector of Strategic Initiatives, American Association of Psychiatric Pharmacists, Lincoln, Nebraska.ORCID https://orcid.org/0000-0002-8592-7280
Jessica HoPsychiatric Clinical Pharmacy Specialist, Kaiser Permanente of the Mid-Atlantic States, Burke, Virginia.ORCID https://orcid.org/0000-0002-4434-6981
Carla CobbPsychiatric Pharmacist, Capita Consulting, Billings, Montana.ORCID https://orcid.org/0000-0002-0827-5485
Elayne D AnsaraClinical Pharmacy Practitioner, Mental Health, Veteran Health Indiana, Indianapolis, Indiana.ORCID https://orcid.org/0000-0001-9835-0305
Clint A RossPsychiatric Pharmacy Coordinator, MUSC Health, Charleston, South Carolina.ORCID https://orcid.org/0000-0002-2684-782X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: A 2019 survey identified significant variability of practice characteristics among outpatient psychiatric pharmacists (OPPs). No published model establishes which attributes constitute best practice for OPPs. By developing a consensus for best practice model attributes, OPPs can work toward consistent, effective patient care. This project aimed to develop attribute statements for a best practice model for OPPs providing direct patient care. Methods: Board Certified Psychiatric Pharmacists and American Association of Psychiatric Pharmacists (AAPP) members were questioned using a 5-phase (P1-P5) survey and summit approach. The phases were: P1, broad ideation survey; P2, 10-person summit to develop draft statements; P3, survey of the draft statements for acceptance; P4, summit to resolve review feedback; and P5, survey of AAPP membership to confirm the finalized statements. Results: P1 survey results generated a list of 143 possible attributes that informed the P2 summit, which were refined to 28 statements. P3 survey results confirmed at least 70% agreement with each statement. The P4 summit evaluated all P3 survey results and made significant modifications to 4 statements. Informal feedback was sought with other stakeholders, and supporting narratives and references were developed to provide clarity regarding the intent of each statement. Finalized statements and supporting narratives were confirmed in the P5 survey. Discussion: The 28 attribute statements were developed over 18 months by gathering input and consensus through multiple modalities, including 3 surveys, 2 summit meetings, and numerous informal feedback requests. The agreement on the attribute statements was consistently high across all phases. The final attribute statements are presented elsewhere in this issue.

Indexed as

attributesbest practiceconsensusoutpatientpsychiatric pharmacy

Identifiers

PMID35582320
PMCPMC9009820

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.